Mutant DNA polymerases

US9376698B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9376698-B2
Application numberUS-5268208-A
CountryUS
Kind codeB2
Filing dateMar 20, 2008
Priority dateJun 28, 2005
Publication dateJun 28, 2016
Grant dateJun 28, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An isolated mutant Tfi DNA polymerase having a D144A point mutation. This polymerase may be used in methods including, but not limited to, nucleic acid synthesis, DNA sequencing, nucleic acid amplification and cDNA synthesis.

First claim

Opening claim text (preview).

What is claimed is: 1. An isolated mutant Tfi DNA polymerase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2 with a D→A point mutation at amino acid position 144 of SEQ ID NO:2 and an E→D point mutation at position 437 of SEQ ID NO:2. 2. The mutant Tfi DNA polymerase of claim 1 , wherein said mutant Tfi DNA polymerase is substantially reduced in 5′-3′ exonucleases activity (exo−) as compared to wild type Tfi DNA polymerase. 3. The mutant Tfi DNA polymerase of claim 2 , wherein said mutant Tfi DNA polymerase has about or less than 10% of the 5′-3′ exonuclease activity as compared to wild type Tfi DNA polymerase. 4. The mutant Tfi DNA polymerase of claim 1 , wherein said mutant Tfi DNA polymerase retains at least 5% of its polymerase activity after heating at 95° C. for 30 minutes as compared to wild type Tfi DNA polymerase. 5. The mutant Tfi DNA polymerase of claim 1 , wherein said mutant Tfi DNA polymerase has increased thermostability as compared to wild type Tfi DNA polymerase. 6. A composition comprising the mutant Tfi DNA polymerase of claim 1 . 7. The composition of claim 6 , further comprising a second Tfi DNA polymerase comprising an amino acid sequence having at least 95% identity to SEQ ID NO:2. 8. The composition of claim 7 , wherein said second Tfi DNA polymerase comprises the amino acid sequence of SEQ ID NO:2. 9. The composition of claim 7 , wherein said second Tfi DNA polymerase is exo+. 10. The composition of claim 7 , wherein said composition comprises a ratio of said mutant Tfi DNA polymerase to said second Tfi DNA polymerase selected from the group consisting of about 9:1, about 8:2, about 7:3, about 6:4, about 5:5, about 4:6, about 3:7, about 2:8, and about 1:9. 11. The composition of claim 9 , further comprising at least two components selected from the group consisting of a detergent, a buffer salt, at least one deoxynucleoside triphosphate (dNTP), and at least one dideoxynucleoside triphosphate (ddNTP). 12. The composition of claim 9 , wherein aid second Tfi DNA polymerase is thermostable.

Assignees

Inventors

Classifications

  • C12P19/34Primary

    Polynucleotides, e.g. nucleic acids, oligoribonucleotides · CPC title

  • Polymerase chain reaction [PCR] · CPC title

  • DNA polymerase · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

  • Taqman · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9376698B2 cover?
An isolated mutant Tfi DNA polymerase having a D144A point mutation. This polymerase may be used in methods including, but not limited to, nucleic acid synthesis, DNA sequencing, nucleic acid amplification and cDNA synthesis.
Who is the assignee on this patent?
Zheng Weidong, Lee Jun E, Potter Robert Jason, and 2 more
What technology area does this patent fall under?
Primary CPC classification C12P19/34. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).